Inactive Instrument

Farmak Stock price

Equities

FARM

UA4000099303

Pharmaceuticals

Dynamic Chart
Public Joint Stock Company "Farmak" acquired Ukrainian business of Novator’s portfolio company from Novator Partners LLP. CI
Public Joint Stock Company "Farmak" acquired Two pharmaceutical marketing companies in the Czech Republic and Slovakia of Novator. CI
Altris, Inc announced that it has received $1 million in funding from a group of investors CI
DrugCard announced that it has received €0.255 million in funding from Public Joint Stock Company "Farmak", Think Bigger Capital, SGEIC, S.A. CI
Public Joint Stock Company "Farmak" Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
ComeBack Mobility announced that it has received $1 million in funding from Fison, Public Joint Stock Company "Farmak", and other investors CI
Public Joint Stock Company Farmak Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Bicovery announced that it has received $0.05 million in funding from Public Joint Stock Company "Farmak" CI
ComeBack Mobility announced that it has received $0.13 million in funding from Public Joint Stock Company "Farmak" and other investors CI
F.I.& P. Holdings Limited acquired additional 6.99% stake in Farmak JSC from Emer Group Limited. CI
Emer Group acquired 6.99% stake in Farmak JSC from Foyil Capital Limited. CI
Farmak Company Announces Board Changes CI
Farmak International Holding GmbH sold 5.50% stake in Farmak Joint Stock Company. CI
Farmak Announces Earnings Results for the Year 2015 CI
Farmak Announces Board Changes CI
More news
Managers TitleAgeSince
Chief Executive Officer 38 07-12-31
Director of Finance/CFO 48 20-12-31
Chairman 74 79-12-31
Members of the board TitleAgeSince
Chairman 74 79-12-31
Director/Board Member - 99-12-31
Director/Board Member 63 22-06-06
More insiders
Farmak PAT (Farmak OJSC) is a Ukraine-based company involved in the chemical and pharmaceutical industry. The Company's product portfolio includes approximately 150 names in various dosage forms: parenteral dosage forms, drops, ointments, tablets and capsules. It is also involved in the production of pharmaceuticals for veterinarian use, pharmaceutical substances synthesis, contract manufacturing, and scientific research. The Company owns such facilities as equipment for labeling and packaging ampoules, production section for drags dosage forms of medicines, and a workshop for ointments, creams, pastes, and gels. Farmak PAT operates on the markets of Ukraine, the Baltic countries, Bulgaria, the Commonwealth of Independent States countries and Poland.
More about the company
  1. Stock
  2. Equities
  3. Stock Farmak - PFTS S.E.